Reuven Or

15.2k total citations · 3 hit papers
303 papers, 10.8k citations indexed

About

Reuven Or is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Reuven Or has authored 303 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Hematology, 94 papers in Immunology and 63 papers in Oncology. Recurrent topics in Reuven Or's work include Hematopoietic Stem Cell Transplantation (141 papers), Immune Cell Function and Interaction (50 papers) and Acute Myeloid Leukemia Research (36 papers). Reuven Or is often cited by papers focused on Hematopoietic Stem Cell Transplantation (141 papers), Immune Cell Function and Interaction (50 papers) and Acute Myeloid Leukemia Research (36 papers). Reuven Or collaborates with scholars based in Israel, United States and Germany. Reuven Or's co-authors include Arnon Nagler, Shimon Slavin, Aliza Ackerstein, E Naparstek, Memet Aker, Chaim Brautbar, Gabriel Cividalli, Simcha Samuel, Gàbor Varadi and S Slavin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Reuven Or

302 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

1998 1.6k citations Shimon Slavin, Arnon Nagler et al. Blood profile →
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

1998 1.5k citations Shimon Slavin, Arnon Nagler et al. Blood profile →
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

2020 484 citations Robert Zeiser, Nikolas von Bubnoff et al. profile →

Peers

Countries citing papers authored by Reuven Or

Since Specialization

Citations

This map shows the geographic impact of Reuven Or's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reuven Or with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reuven Or more than expected).

Fields of papers citing papers by Reuven Or

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reuven Or. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reuven Or. The network helps show where Reuven Or may publish in the future.

Co-authorship network of co-authors of Reuven Or

This figure shows the co-authorship network connecting the top 25 collaborators of Reuven Or. A scholar is included among the top collaborators of Reuven Or based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reuven Or. Reuven Or is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Modulate Apoptosis, TNF Alpha and Interferon Gamma Response Gene mRNA Expression in T Lymphocytes 2023 ·International Journal of Molecular Sciences ·(unknown), Drirh Khare, (unknown), Reuven Or, Amnon Buxboim, Boaz Nachmias, (unknown), Regina Golan‐Gerstl, Swasti Tiwari, Polina Stepensky, Yuval Nevo, Hadar Benyamini, Sharona Elgavish, Osnat Almogi‐Hazan, Batia Avni	4
2	Feline cognitive dysfunction as a model for Alzheimer’s disease in the research of CBD as a potential treatment—a narrative review 2020 ·Journal of Cannabis Research ·(unknown), (unknown), Vered Hermush, Nethanel Asher, Avi Avital, Reuven Or	3
3	Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back 2020 ·International Journal of Molecular Sciences ·Osnat Almogi‐Hazan, Reuven Or	95
4	Biomarker Analysis in Patients (pts) with Steroid-Refractory Acute Graft-Vs-Host Disease (aGVHD) Treated with Ruxolitinib (RUX) or Best Available Therapy (BAT) in the Randomized, Phase 3 REACH2 Study 2020 ·Blood ·Gèrard Socié, Dietger Niederwieser, Nikolas von Bubnoff, Mohamad Mohty, Jeff Szer, Reuven Or, Jason Butler, Eva Wagner, Édouard Forcade, Jaime Sanz, Domenico Russo, Giovanni Grillo, Tsila Zuckerman, Sinem Civriz Bozdağ, David Ritchie, Shalini Chaturvedi, Anirudh Prahallad, (unknown), Celine Wilke, Robert Zeiser	2
5	Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients 2019 ·PLoS ONE ·Liad Hinden, (unknown), Polina Stepensky, Reuven Or, Osnat Almogi‐Hazan	10
6	Graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy? 2018 ·Clinical Case Reports ·(unknown), Ioana Maria Lambrescu, (unknown), Anca Coliţă, Reuven Or, Simona Fica	6
7	Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers 2017 ·Clinical Cancer Research ·Michal Abraham, Yaron Pereg, Baruch Bulvik, Shiri Klein, Inbal Mishalian, (unknown), Orly Eizenberg, Katia Beider, Arnon Nagler, (unknown), (unknown), (unknown), Eithan Galun, Yoseph Caraco, Reuven Or, Amnon Peled	41
8	PreImplantation factor (PIF) regulates systemic immunity and targets protective regulatory and cytoskeleton proteins 2016 ·Immunobiology* ·Eytan R. Barnea, Soren Hayrabedyan, Krassimira Todorova, Osnat Almogi‐Hazan, Reuven Or, Joy Guingab, (unknown), Nelson Fernández, Timothy J. Barder	18
9	Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells 2005 ·Experimental Hematology ·Menachem Bitan, Michael Y. Shapira, Igor Resnick, (unknown), (unknown), Simcha Samuel, Aliza Ackerstein, Elad Sharon, (unknown), Avraham Amar, Eitan Fibach, Reuven Or, Shimon Slavin	27
10	Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients 2004 ·Bone Marrow Transplantation ·M Y Shapira, Igor Resnick, Menachem Bitan, Aliza Ackerstein, S Samuel, Elad Sharon, (unknown), (unknown), S Slavin, Reuven Or	25
11	Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients 2003 ·Supportive Care in Cancer ·Elad Sharon, Adi A. Garfunkel, Reuven Or, (unknown), Michael Y. Shapira, D Galili	37
12	Donor Lymphocyte Infusion: The Use of Alloreactive and Tumor-Reactive Lymphocytes for Immunotherapy of Malignant and Nonmalignant Diseases in Conjunction with Allogeneic Stem Cell Transplantation 2002 ·Journal of Hematotherapy & Stem Cell Research ·Shimon Slavin, Shoshana Morecki, Lola Weiss, Reuven Or	40
13	Peripheral stem cells are the preferred source of stem cells for autologous stem cell transplantation (ASCT) of young patients with MDS or AML following MDS: An analysis of the chronic leukaemia working party of the European blood and marrow transplantation group (EBMT) 2001 ·Blood ·T de Witte, R. Brand, Anja van Biezen, Michel Delforge, (unknown), Reuven Or, William Arcese, (unknown), Jorge Sierra, J Cahn, Marie‐Cécile Michallet, Sergio Amadori, D Niederwieser, Aloïs Gratwohl, (unknown)	4
14	Should Soybean Agglutinin Purging Be Performed in Breast Cancer Patients Undergoing Autologous Stem Cell Transplantation? 1997 ·American Journal of Clinical Oncology ·Rami Ben‐Yosef, Reuven Or, E Naparstek, Joseph Kapelushnik, (unknown), Shimon Slavin, Arnon Nagler	4
15	Invasive fungal infections in lymphoma patients receiving immunotherapy following autologous bone marrow transplantation (ABMT) 1997 ·Bone Marrow Transplantation ·Amos Toren, Reuven Or, Aliza Ackerstein, Arnon Nagler	18
16	Endodontic therapy for mental nerve neuropathy in systemic cancer patients 1988 ·Journal of Endodontics ·Ilan Rotstein, D Galili, Reuven Or	6
17	PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA BY T-CELL DEPLETION INVITRO PRIOR TO TRANSPLANTATION 1985 ·Transplantation Proceedings ·Shimon Slavin, Herman Waldmann, Reuven Or, Gabriel Cividalli, E Naparstek, (unknown), Joseph Michaeli, E. Galun, (unknown), S Samuel, Shoshana Morecki, (unknown), (unknown), Z Weshler, G Hale, E. A. Rachmilewitz, Yaīr Reisner	21
18	Captopril-Associated Transient Aplastic Anemia 1985 ·Acta Haematologica ·A Israeli, Reuven Or, Eran Leitersdorf	13
19	Bronchopulmonary Candidiasis Exacerbating Asthma 1985 ·Respiration ·Dov Wengrower, Reuven Or, Esther Segal, Yosef Kleinman	1
20	Hairy Cell Leukemia: Report of an Unusual Case with Hepatomegaly due to a Large Vascular Tumor of the Liver, Mediastinal Mass and Pleural Effusion Containing Hairy Cells 1984 ·Acta Haematologica ·Itamar Raz, Reuven Or, (unknown), (unknown), Aaron Polliack	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact